Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ensysce Biosciences, Inc. - Common Stock
(NQ:
ENSC
)
0.5841
+0.0091 (+1.58%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ensysce Biosciences, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Over $12 Million Bet On TD Holdings? Check Out These 3 Penny Stocks Insiders Are Buying
↗
February 02, 2023
The Federal Reserve on Wednesday raised its benchmark rate by 0.25%, marking the central bank's second consecutive policy downshift. When insiders purchase or sell shares, it indicates their confidence...
Via
Benzinga
Ensysce Biosciences Announces the Distribution of Series A Preferred Stock to Holders of Its Common Stock
February 01, 2023
Via
ACCESSWIRE
Why Ensysce Biosciences Stock Is Exploding Higher During Wednesday's Session
↗
January 25, 2023
Ensysce Biosciences Inc (NASDAQ: ENSC) shares are trading higher by 21.81% to $0.82 Wednesday after the company announced initiation of the final stage of its opioid overdose protection Phase 1 study....
Via
Benzinga
Nasdaq Falls 50 Points; eHealth Shares Spike Higher
↗
January 25, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 50 points on Wednesday. The Dow traded down 0.12% to 33,694.64 while the NASDAQ fell 0.44% to 11,284.18....
Via
Benzinga
Ensysce Biosciences Announces Initiation of Final Stage of Groundbreaking Opioid Overdose Protection Phase 1 Study
January 25, 2023
Via
ACCESSWIRE
Ensysce Biosciences Announces Successful Completion of Clinical Portion of Oral Human Abuse Potential Trial
January 04, 2023
Via
ACCESSWIRE
Ensysce Biosciences's Return On Capital Employed Overview
↗
December 27, 2022
Via
Benzinga
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
January 25, 2023
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.
Via
Benzinga
Nasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings
↗
January 25, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Wednesday. The Dow traded down 1.10% to 33,364.09 while the NASDAQ fell 1.92% to 11,116.96....
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
January 25, 2023
Via
Benzinga
Ensysce Biosciences Announces Data from PF614-MPAR-101-Part A Successfully Demonstrating Opioid Overdose Protection
December 19, 2022
Via
ACCESSWIRE
Ensysce Biosciences to Present at Diamond Equity Research 2023 Virtual Emerging Growth Invitational
January 23, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
↗
January 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
January 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
January 12, 2023
Via
Benzinga
Ensysce Biosciences Issues 2023 Shareholder Letter
January 11, 2023
Via
ACCESSWIRE
Analyzing Ensysce Biosciences's Short Interest
↗
January 06, 2023
Ensysce Biosciences's (NASDAQ:ENSC) short percent of float has fallen 83.99% since its last report. The company recently reported that it has 143 thousand shares sold short, which is 2.6% of all...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
January 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
December 28, 2022
Via
Benzinga
How Is The Market Feeling About Ensysce Biosciences?
↗
December 21, 2022
Ensysce Biosciences's (NASDAQ:ENSC) short percent of float has risen 128.73% since its last report. The company recently reported that it has 315 thousand shares sold short, which is 16.24% of all...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
December 19, 2022
Via
Benzinga
Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket
↗
December 12, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
December 23, 2022
OnFriday, 143 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
December 14, 2022
On Wednesday, 115 stocks hit new 52-week lows.
Via
Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
↗
December 12, 2022
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Via
Benzinga
Dow Edges Higher; Prometheus Biosciences Shares Jump
↗
December 07, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 0.5% on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
December 07, 2022
Via
Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
↗
December 09, 2022
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
Via
Benzinga
Nasdaq Drops 75 Points; Crude Oil Down 2%
↗
December 07, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping 75 points on Wednesday.
Via
Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
↗
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
